⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Metabolon, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Metabolon, Inc.
↗Morrisville, North Carolina, USA
Metabolon is a global leader in metabolomics, providing advanced biochemical profiling and multiomics solutions to the life sciences industry. The company utilizes a proprietary platform that integrates ultra-high-performance liquid chromatography and tandem accurate mass spectrometry with an extensive biochemical reference library to identify and quantify metabolites.
By delivering actionable insights into health, disease, nutrition, and the environment, Metabolon supports researchers across the entire drug development lifecycle—from discovery and target identification to clinical trials and product life-cycle management. The company serves a diverse clientele, including top pharmaceutical, biotechnology, and academic institutions, helping them accelerate pipeline progression and optimize clinical assets.
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Bioinformatics, Diagnostics, Life Science Research Tools
SIZE & FINANCIALS
Employees:201-500
Founded:2000
Ownership:private
Status:operating
FUNDING
Stage:Late Stage VC
Investors:EW Healthcare Partners, Essex Woodlands, Perceptive Advisors, Trinity Capital
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Gilead Sciences/Kite (Metabolomic analysis for CAR T-cell therapy studies)
COMPETITION
Position:Leader
Competitors:Creative Proteomics, Biocrates, Metabolomic Diagnostics
LEADERSHIP
Key Executives:
Rohan Hastie, Ph.D. - President & CEO
Gerald Haines II - CFO
Rangaprasad Sarangarajan, Ph.D. - CSO
LINKS
Website:metabolon.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Metabolon, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.